- Terms of use
- Privacy Notice
- Accessibility
- Cookie Policy
- ©2024 Freeline
Henning Stennicke
Chief Scientific Officer
Henning has more than 25 years of experience in scientific research and leadership. Prior to joining Freeline in March 2022, he held leadership positions at Novo Nordisk, including shepherding new treatments for growth disorders, hemophilia and sickle cell disease through clinical development and regulatory approval. Henning received a Master of Science in biochemistry and a doctorate in protein chemistry from the University of Copenhagen and the Carlsberg Laboratory and held a postdoctoral position at the Sanford Burnham Prebys Medical Discovery Institute. He has a Master of Business degree from the Technical University of Denmark.
Connect with Henning: